iBio (IBIO) Accounts Payables (2011 - 2026)
iBio (IBIO) posted quarterly Accounts Payables of $3.0 million for Q1 2026, up 105.48% year-over-year from $1.5 million in Q1 2025, and up 14.36% quarter-over-quarter from $2.7 million in Q4 2025.
iBio (IBIO) Accounts Payables (2011 - 2026) Analysis & Trends
iBio (IBIO) has reported Accounts Payables for 16 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 105.48% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (up 105.48% YoY), while the FY2025 annual figure was $2.2 million, up 511.17% from the prior year.
- Accounts Payables advanced to $3.0 million in Q1 2026 per IBIO's latest filing, from $2.7 million in the prior quarter.
- Across five years, Accounts Payables topped out at $5.3 million in Q1 2022 and bottomed at $358000.0 in Q2 2024.
- Historically, Accounts Payables has averaged $2.4 million across 5 years, with a median of $2.0 million in 2023.
- Annual changes were most pronounced in 2024 — Accounts Payables plunged 80.64% — and 2025, when it jumped 511.17%.
- iBio's Accounts Payables stood at $4.0 million in 2022, then sank by 53.55% to $1.9 million in 2023, then tumbled by 66.97% to $614000.0 in 2024, then surged by 332.25% to $2.7 million in 2025, then gained by 14.36% to $3.0 million in 2026.
- Business Quant data shows IBIO's Accounts Payables at $3.0 million in Q1 2026, $2.7 million in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.04 Mn |
| Dec 31, 2025 | 2.65 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | 2.19 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 614,000.00 |
| Sep 30, 2024 | 855,000.00 |
| Jun 30, 2024 | 358,000.00 |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 1.85 Mn |
| Mar 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 4.81 Mn |
| Jun 30, 2022 | 4.26 Mn |
| Mar 31, 2022 | 5.28 Mn |
| Dec 31, 2021 | 2.74 Mn |
| Sep 30, 2021 | 2.29 Mn |
| Jun 30, 2021 | 2.25 Mn |